OpenAI acquires biotech AI startup Orchestra Bio
What happened
On 21 October 2026, TechCrunch reported that OpenAI announced on Tuesday its acquisition of Orchestra Bio, a four-year-old AI biotech software startup. The terms of the deal were not disclosed. The company had raised about $20 million by 2025, with investors including Andreessen Horowitz, Atria and 8VC, according to the report. OpenAI said the move is intended to strengthen its life sciences business. There is no further information yet on the purchase price, integration arrangements or future business plans.
Written by AI from the reports · updated 3 h ago
Timeline
Follow the reports to see the event from each side.
- TechCrunch · AIOpenAI acquires startup Orchestra Bio to beef up its biotech business
OpenAI says it's adding Orchestra's team and technology to work on Rosalind, its AI model for life sciences research, and to its related Rosalind Workbench tool, a harness that aims to help researchers plan experiments and analyze results.
Heat of this event
Current heat 9·Peak in the comparable range 9（Oct 21 07:00）·Change over 24 hours in the comparable range –
The trend compares only the same accounts observed without a break, so its range can be narrower than the current heat count. Move the pointer or tap the chart to see each hour; with a keyboard, use the left and right arrow keys.